27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Initiations

No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating Initiation News

Wells Fargo Initiates Coverage On UL Solutions with Overweight Rating, Announces Price Target of $40
Wells Fargo initiates coverage on UL Solutions (NYSE:ULS) with a Overweight rating and announces Price Target of $40.
William Blair Initiates Coverage On UL Solutions with Outperform Rating
William Blair analyst Andrew Nicholas initiates coverage on UL Solutions (NYSE:ULS) with a Outperform rating.
UBS Initiates Coverage On UL Solutions with Neutral Rating, Announces Price Target of $38
UBS analyst Joshua Chan initiates coverage on UL Solutions (NYSE:ULS) with a Neutral rating and announces Price Target of $38.
Citigroup Initiates Coverage On UL Solutions with Buy Rating, Announces Price Target of $41
Citigroup analyst Arthur Truslove initiates coverage on UL Solutions (NYSE:ULS) with a Buy rating and announces Price Target of $41.
Citigroup Initiates Coverage On Summit Therapeutics with Buy Rating, Announces Price Target of $7
Citigroup analyst Yigal Nochomovitz initiates coverage on Summit Therapeutics (NASDAQ:SMMT) with a Buy rating and announces Price Target of $7.
JP Morgan Initiates Coverage On UL Solutions with Overweight Rating, Announces Price Target of $39
JP Morgan analyst Stephanie Yee initiates coverage on UL Solutions (NYSE:ULS) with a Overweight rating and announces Price Target of $39.
Jefferies Assumes Pyxis Oncology at Buy, Announces Price Target of $10
Jefferies analyst Farzin Haque assumes Pyxis Oncology (NASDAQ:PYXS) with a Buy rating and announces Price Target of $10.
Jefferies Initiates Coverage On UL Solutions with Buy Rating, Announces Price Target of $42
Jefferies analyst Stephanie Moore initiates coverage on UL Solutions (NYSE:ULS) with a Buy rating and announces Price Target of $42.
Raymond James Initiates Coverage On UL Solutions with Outperform Rating, Announces Price Target of $42
Raymond James analyst Brian Gesuale initiates coverage on UL Solutions (NYSE:ULS) with a Outperform rating and announces Price Target of $42.
Goldman Sachs Initiates Coverage On UL Solutions with Neutral Rating, Announces Price Target of $39
Goldman Sachs analyst George Tong initiates coverage on UL Solutions (NYSE:ULS) with a Neutral rating and announces Price Target of $39.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free